ReFlow Therapeutics' Grant

ReFlow Therapeutics raised a round of funding on February 01, 2017. Investors include Swiss Commission of Technology and Innovation.

ReFlow Therapeutics develops diagnostic and therapeutic medical devices for improving microvascular obstructions after a heart attack.…

Articles about ReFlow Therapeutics' Grant: